EUVIMEDEUVIMED entdecken
Editorial

Redefining Disease Progression in ATTR-CM: Beyond Biomarkers to Patient-Centered Outcomes

Joban Vaishnav, Jan M Griffin

Journal of Cardiac Failure · 2026-05 · 32 (5) · 821-823

DOI: 10.1016/j.cardfail.2026.02.021 ↗

Kurz gefasst

Editorial in der Zeitschrift Journal of Cardiac Failure, 2026-05. Verfasst von Joban Vaishnav und 1 weiteren Autor:innen. Beteiligte Einrichtung: Johns Hopkins Hospital, Baltimore Maryland. Electronic address: jvaishn1@jhmi.edu. Die Arbeit nennt 8 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Autor:innen und Institutionen

  • Johns Hopkins Hospital, Baltimore Maryland. Electronic address: jvaishn1@jhmi.edu.
  • Medical University of South Carolina, Charleston, South Carolina.

Zitieren

APA

Vaishnav, J., & Griffin, J. M. (2026). Redefining Disease Progression in ATTR-CM: Beyond Biomarkers to Patient-Centered Outcomes. Journal of Cardiac Failure, 32(5), 821-823. https://doi.org/10.1016/j.cardfail.2026.02.021

Vancouver

Vaishnav J, Griffin JM. Redefining Disease Progression in ATTR-CM: Beyond Biomarkers to Patient-Centered Outcomes. Journal of Cardiac Failure. 2026;32(5):821-823. doi:10.1016/j.cardfail.2026.02.021

BibTeX
@article{Vaishnav2026,
  author = {Vaishnav, Joban and Griffin, Jan M},
  title = {Redefining Disease Progression in ATTR-CM: Beyond Biomarkers to Patient-Centered Outcomes},
  journal = {Journal of Cardiac Failure},
  year = {2026},
  volume = {32},
  number = {5},
  pages = {821--823},
  doi = {10.1016/j.cardfail.2026.02.021}
}
Kostenlos starten →